Ulrik Lassen

Researcher Next ID · RN-038674

Researcher · Biochemistry, Genetics and Molecular Biology

Copenhagen, Denmark

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Glioma Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Lung Cancer Treatments and Mutations

Cancer Genomics and Diagnostics

CAR-T cell therapy research

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
Nature Medicine · 2023 · https://doi.org/10.1038/s41591-023-02321-8
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30321-1
Actively personalized vaccination trial for newly diagnosed glioblastoma
Nature · 2018 · https://doi.org/10.1038/s41586-018-0810-y
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1714448

No projects listed.